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Abstracts / Osteoarthritis and Cartilage 21 (2013) S1–S8S6We have shown that the non-receptor tyrosine kinase Src phosphory-
lates syndecan-4 to suppress activation of the small GTPase Arf6.
Crucially, syndecan-4-mediated Arf6 activity differentially regulates
recycling of the a5b1 and aVb3 integrin heterodimers to themembrane,
to control adhesion complex dynamics. Thus, syndecan-4 phosphory-
lation functions as a molecular switch to target speciﬁc integrin het-
erodimers to the membrane and modulate FA stability and matrix
remodelling. We propose that maintenance of normal tissue architec-
ture and function requires the precise spatial and temporal regulation of
syndecan-4 phosphorylation, to coordinate integrin trafﬁcking,
dynamically regulate interaction with the matrix, and to control cell
migration and the integrity of the extracellular environment.
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FEMORAL SHAPE AND IMPINGEMENT
H. Weinans. UMC Utrecht, Utrecht, Netherlands
From a mechanical perspective congruency of the joint is important
for appropriate articulation with mechanical loading that is well
distributed over the joint surface. Whereas severe abnormal shapes
clearly create an articulation problem and can lead to OA, it is
currently recognized that subtle shape differences can be a risk factor
for OA as well. Bone shapes vary between persons and likely there are
good and bad shapes with respect to joint functioning. Variations of
bone shape among the population have been investigated ever since
the introduction of radiographic imaging. The idea that in hip OA
many cases of primary OA is actually secondary to a non-optimal
shape of the joint goes many years back. For example Perthes' disease,
slipped capital femoral epiphysis and congenital hip dysplasia clearly
pose a high risk for developing OA. Therefore mild subclinical forms of
these pathological conditions might also form a (smaller) risk factor of
OA. Many shape aspects have been identiﬁed that are associated with
OA such as: a decreased anteversion angle of the femoral neck,
retroversion of the acetabulum, a deep acetabular socket or a non-
spherical head shape. These are all well (pre)deﬁned geometry
aspects. However it is not straightforward to quantify shape variations
in general and new methods have recently been introduced that can
help to identify and ﬁnd subtle aspects of shape variation within
a given population. The importance of these variations in relation to
OA development or OA progression has only started to be uncovered
recently.
The most thorough method to determine shape variations from radio-
graphic images is using so-called statistical shape or appearance
models, where the latter also provides the density variation. In these
models a contour is created along landmark points of the bone that
together annotate the shape. For a given population all contours can
now be compared through scaling and rotation to obtain a best ﬁt.
Subsequently the contour coordinates are recombined with principal
component analysis to derive independent components (modes) that
represent the variation in shape within that population. Using this
methodology speciﬁc shape modes can be found that are strongly
associated with OA and even certain geometries of the hip were iden-
tiﬁed that correlate with OA characteristics dependent on the carrier
status of the DIO2 gene SNP.
A more direct approach is to use predeﬁned shape parameters that are
suspect of contributing to OA. One of the most well studied parame-
ters in this respect is sphericity of the femoral head. A non-spherical
head might create a diminished range of motion of the hip joint as
a consequence of femoral acetabular impingement. This problem has
been well described lately by Ganz and coworkers and often concerns
the formation of extra bone at the antero-lateral head neck junction;
a so-called Cam-type deformity. There is now general consensus that
this deformity is initiated during puberty, likely induced by mechan-
ical loading such as high impact sport activities and not evolves
with time in adults. However many clinical studies do show that
severe clinical problems related to Cam impingement become evident
at adult (but relatively young) age and there is a current trend to
operatively remove the Cam deformity in order to prevent OA later in
life.
The current work on shape analyses can provide imaging related (bio)
markers that might predict OA initiation and/or progression. These
shape related reasons of OA puts the deﬁnition of ‘idiopathic’ or primary
OA in a new context. Furthermore new tools to quantify joint shape can
help to elucidate more subtle risk factors and ﬁnd cause effect rela-
tionships related to genes that contribute to OA.I-19
HEDGEHOG SIGNALING IN OSTEOARTHRITIS
B. Alman. Hosp. for Sick Children, Toronto, ON, Canada
Purpose: Hedgehog signaling plays a critical role in chondrocytes
during development and as such could also play a role in articular
chondrocyte degeneration. This study will determine the role of
hedgehog signaling and in cartilage degeneration and osteoarthritis.
Methods: Human osteoarthritis samples were examined to deter-
mine if hedgehog signaling is dysregulated in osteoarthritis. Using
array analysis and chromatin immunoprecipitation, hedgehog target
genes were identiﬁed. Genetically modiﬁed mice in which hedgehog
transcriptional activation can be modulated and in which
target genes can be modiﬁed were used to determine how this
modulates spontaneous and traumatic onset articular cartilage
degeneration.
Results: Hedgehog signaling is activated in human and murine osteo-
arthritis. Inhibiting hedgehog signaling pharmacologically or geneti-
cally inhibits the development of osteoarthritis, while activating the
pathway worsens the severity of cartilage degeneration. Hedgehog
signaling regulated genes that modulate intracellular cholesterol. Mice
lacking the ability to degrade cholesterol in chondrocytes developed
worse cartilage degeneration and inhibiting cholesterol decreased the
severity of osteoarthritis.
Conclusions: Hedgehog signaling and its target genes regulate articular
cartilage degeneration. Pharmacologic inhibition of hedgehog signaling
or intracellular cholesterol could be used as a therapeutic approach to
prevent or treat cartilage degeneration in osteoarthritis.
I-20
WE SHOULD TREAT PAIN!
M.C. Hochberg. Univ. of Maryland, Baltimore, MD, USA
Persons with structural changes of osteoarthritis (OA) become patients
when they present to health care providers with symptomatic
complaints; most often pain, aching or discomfort, but also stiffness.
These symptoms may be accompanied by signs on physical exami-
nation consistent with OA with or without local inﬂammation. This
presentation will focus on 1) the impact of symptoms of OA on activity
limitation, physical disability and reduced health-related quality of life
and 2) the effect of improvement in pain on reduction in activity
limitation and physical disability and improvement in health-related
quality of life.
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MOUSE MODELS OF JOINT DISORDERS
M.J. Hilton. Univ. of Rochester Med. Ctr., Rochester, NY, USA
Over the last decade, mice have become a valuable tool in the study of
joint disorders. The primary reasons for this include the high degree of
similarities that exist between human and mouse joint structures and
the genes/proteins involved in joint development and maintenance,
the genetic tractability of the mouse, and the develop of methods for
the surgical and chemical induction of joint cartilage degeneration.
The use of mice and the development of unique murine models of
joint disorders have provided enormous insight into the molecular
underpinnings of human cartilage related joint diseases. In particular,
the use of the Cre-LoxP technology to generate tissue and temporal
speciﬁc gene deletions/activations within joint tissues has identiﬁed
speciﬁc genes and pathways implicated in normal articular cartilage
development and joint maintenance and pathological joint degener-
ation. Similarly, the surgical destabilization of murine knee joints has
served as an important platform for studying the progression of
osteoarthritis (OA) and the genes involved in that process. During the
course of this workshop we will discuss several important murine
models of joint disorders, with a particular emphasis on 1) the utili-
zation of murine surgical models of knee joint destabilization to test a)
the involvement of speciﬁc genes in OA progression and b) the
effectiveness of potential disease modifying osteoarthritis drugs
(DMOADs), 2) the selection and utility of various Cre transgenic mice
for temporal and tissue speciﬁc gene deletions/activations in joint
tissues, and 3) the speciﬁc roles that various genetic pathways
(Wnt/Beta-catenin, TGFb, Ihh, and Notch) play in regulating anabolic
and catabolic factors that are important for normal articular cartilage
and joint maintenance.
